United States · Bill · S
S. 2477 (116th)
National Commission on Scleroderma and Fibrotic Diseases Act of 2019
Introduced
12 September 2019
Last action
—
Status
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Sponsors
—
Subjects
Discovery layer
Source updated
5 December 2025
Summary
National Commission on Scleroderma and Fibrotic Diseases Act of 2019 This bill temporarily establishes a National Commission on Fibrotic Diseases within the National Institutes of Health that must recommend improvements regarding fibrosis and fibrotic disease research.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
3 official files
Introduced in Senate (text)
Introduced in Senate · EN · 12 September 2019
Introduced in Senate (PDF)
Introduced in Senate · EN · 12 September 2019
Introduced in Senate
summary · EN · 12 September 2019
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/116th-congress/senate-bill/2477
- Open data entity: https://api.congress.gov/v3/bill/116/s/2477